ALX Oncology Holdings Inc.

US$1.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALXOHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (41.32%)
Div yield —
ROE (80.65%)
Biotechnology
Beta (5Y) 0.56
PE TTM —
TSR TTM (25.00%)
Mkt cap US$159.7M
ROIC (45.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.31
13.52%
184.93%
Hold 4|1|4|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.01
0.02
0.02
33.37%
15.17%
7.33%
5.36%
Revenue$M
9.258
9.107
8.898
8.929
8.52%
8.74%
1.28%
(0.57%)
Peers (US$159.7M)
Cap (US$)
PE
159.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.913
2.014
1.565
EBIT/Intx
2.228
1.473
1.387
Own earn%
217.64
(124.46)
(103.78)
Sh yield%
25.24
18.52
23.53
Owners
Insiders/Inst%
12.67
59.52
Short interest%
2.45
SBC / revenue%
2.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
4